Rubella Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
Condition:   Diarrhoea Interventions:   Drug: altSonflex Placebo;   Biological: altSonflex1-2-3 Dose C;   Biological: altSonflex1-2-3 Dose B;   Biological: altSonflex1-2-3 Dose A;   Biological: GSK's Meningococcal A, C, Y and W-135 conjugate vaccine;   Combination Product: GSK's Tetanus toxoid, reduced diphtheria toxoi d and acellular pertussis vaccine;   Combination Product: GSK's Poliomyelitis, diphtheria, tetanus and pertussis vaccine;   Combination Product: Sanofi Pasteur's Typhoid Vi polysaccharide vaccine;   Biological: Serum Institute of India's Measles and rubella vaccine Sponsor:   GlaxoSmith...
Source: ClinicalTrials.gov - October 11, 2021 Category: Research Source Type: clinical trials